Biomed Central Ltd

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Offit
    Offit
  5. Budhu
    Budhu
  6. Motzer
    Motzer
  7. Shoushtari
    Shoushtari
  8. Cheung
    Cheung
  9. Voss
    Voss
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (566)
  2. Solid Tumor Oncology Division (461)
  3. GSK Faculty (295)
  4. Sloan Kettering Institute Postdocs (194)
  5. Hematologic Malignancies, Division of (160)
  6. Population Sciences Research Program (158)
  7. Epidemiology and Biostatistics (153)
  8. Melanoma and Immunotherapeutics Service (148)
  9. Surgery (123)
  10. Survivorship Research (120)
Search Within
Formats
  1. Journal Article (751)
  2. Meeting Abstract (257)
  3. Review (40)
  4. Guidelines (20)
  5. Editorial (11)
  6. Research Letter (7)
  7. Correspondence (4)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (566)
  2. Solid Tumor Oncology Division (461)
  3. GSK Faculty (295)
  4. Sloan Kettering Institute Postdocs (194)
  5. Hematologic Malignancies, Division of (160)
  6. Population Sciences Research Program (158)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Andrew Vickers (44)
  4. Michael Postow (43)
  5. Matthew Hellmann (30)
  6. Sandra D'Angelo (26)

More People

Years
  1. 2025 (40)
  2. 2024 (60)
  3. 2023 (44)
  4. 2022 (122)
  5. 2021 (91)
  6. 2020 (99)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (412)
  2. Breast Cancer Research (67)
  3. BMC Cancer (65)
  4. Genome Biology (47)
  5. Journal of Hematology & Oncology (43)
  6. Journal of Translational Medicine (35)

More Publications

Results (1092)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Laminar Wash™ AUTO system: A reliable walk-away sample preparation solution for better TIL recovery without centrifugation
    Meeting Abstract

    Kim, I.; Lye, M.; Zappasodi, R.; Schulze, I.; Eberle, C.; Ke, C. Y.; Cheng, K. L.; Kon, I. C.; Pek, R.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Phase 1 trial of NY-ESO-1-specific adoptive T-cell therapy with GSK3377794 in patients with advanced synovial sarcoma
    Meeting Abstract

    D'Angelo, S.; Demetri, G.; Van Tine, B.; Druta, M.; Glod, J.; Chow, W.; Tress, J.; DeYoung, M. P.; Hasan, A.; Wu, Y.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+ previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study design
    Meeting Abstract

    D'Angelo, S.; Blay, J. Y.; Chow, W.; Demetri, G.; Thistlethwaite, F.; Wagner, M.; Loeb, D.; Attia, S.; Razak, A.; Haanen, J.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • A phase 2 efficacy and safety trial of ADU-S100 and pembrolizumab in adults with head and neck cancer
    Meeting Abstract

    Cohen, E.; Ferris, R.; Adkins, D.; Zandberg, D.; Dudek, A.; Mathew, M.; Dunn, L.; Grilley-Olson, J.; Sukari, A.; Redman, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • A phase 1/2 study of GB1275, a novel CD11b modulator, as monotherapy and with an anti-PD-1 antibody in specified advanced solid tumors or with chemotherapy in metastatic pancreatic cancer (mPDAC)
    Meeting Abstract

    Bendell, J.; Rasco, D.; Park, W.; Zhou, L.; Galkin, A.; Slee, D.; Carter, L.; Nickle, D.; Tran, R.; Li, J.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease
    Meeting Abstract

    Abu-Sbeih, H.; Faleck, D.; Ricciuti, B.; Mendelsohn, R.; Naqash, A. R.; Cohen, J.; Sellars, M.; Balaji, A.; Ben-Betzalel, G.; Hajir, I.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • An EM algorithm to improve the estimation of the probability of clonal relatedness of pairs of tumors in cancer patients
    Journal Article

    Mauguen, A.; Seshan, V. E.; Ostrovnaya, I.; Begg, C. B.
    BMC Bioinformatics (2019)

    Fulltext@MSK | Save
  • Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: Results of a phase 3, randomized, controlled trial
    Journal Article

    Montillo, M.; Illés, A.; Robak, T.; Pristupa, A. S.; Wach, M.; Egyed, M.; Delgado, J.; Jurczak, W.; Morschhauser, F.; Schuh, A.; more...
    Health and Quality of Life Outcomes (2019)

    Fulltext@MSK | Save
  • Dual checkpoint inhibitor-associated eosinophilic enteritis
    Journal Article

    Yang, J.; Lagana, S. M.; Saenger, Y. M.; Carvajal, R. D.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save